The forest plots of the effect of probiotics on the level of IL-10 by ELISA (A) and RT-PCR (B) methods. by Zahra Zangeneh (11772967)

ZfpA overexpression decreases voriconazole efficacy <i>in vitro</i> and during infection. by Taylor J. Schoen (15383519)

Therapeutic effect of TAS5315 on the decrease in bone strength in a mouse CIA model. by Daichi Akasaka (14670684)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

“…NF-κB p65 staining was higher in the NF group than controls (0.43 ± 0.11% vs. 0.11 ± 0.05%, <i><i>p</i> </i>< 0.05) and decreased with low and high GJE doses (0.22 ± 0.04% and 0.29 ± 0.10%, respectively, <i><i>p</i> </i>< 0.05), though the high-dose group remained elevated versus controls (0.29 ± 0.10% vs. 0.11 ± 0.05%, <i><i>p</i> </i>< 0.05). …”

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

A summary of the included study characteristics. by Zahra Tajik (20752452)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Number of pulmonary endothelial cells decreased upon infection and started to proliferate during resolution to restore their number by 15 dpi accompanied by decreased endothelial a... by Emilie Pollenus (10147748)